Bodimetrics

What Bodimetrics does

BodiMetrics is a US-based, privately held LLC headquartered in Manhattan Beach, founded in 2015, operating with a small team of 11–50 employees. The company develops wearable health-monitoring hardware, historically positioning its products as consumer-facing vital-health-metric capture devices. In December 2024, BodiMetrics narrowed its strategic focus to sleep apnea by partnering with EnsoData Inc. and launching an FDA-cleared, AI-powered wearable device designed for accessible home-based sleep apnea detection. The product analyzes physiological sensor data through AI algorithms to detect apnea events and patterns, enabling users to conduct sleep testing without visiting clinical facilities.

The company's core offering — the BodiMetrics Sleep Apnea Detection Device — combines proprietary wearable hardware with EnsoData's AI-based sleep analysis software. Leadership is concentrated: Mark Goettling serves as Co-Founder, CEO, and CFO, Neil Friedman as Co-Founder and COO, and Doug Wolfgram as CTO. The combined CEO/CFO role is typical of early-stage companies with limited financial staffing and suggests a lean operating model.

The revenue model and pricing are not publicly disclosed, and no go-to-market details, named customers, distribution channels, marketing channels, or funding rounds appear in the available data. The company appears to be founder-controlled with no disclosed institutional investors, parent entity, or M&A history. Operating geographies, regulatory certifications beyond FDA clearance, and detailed product economics cannot be determined from the input.

Name

Bodimetrics

Legal name

BodiMetrics LLC

Website

https://bodimetrics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

BodiMetrics is a privately held US company that develops FDA-cleared AI-powered wearable devices for home-based sleep apnea detection, in partnership with EnsoData Inc., serving healthcare consumers seeking accessible diagnostic alternatives to clinical sleep studies.

Ownership category

akta.pro rank

Product category

Wearable Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)

akta.pro secondary industry

Sleep Tech Wearables (CRACAIAG)

Keywords

• Sleep apnea detection
• Wearable health monitor
• Home sleep testing
• FDA cleared medical device
• AI health monitoring

Headquarters

HQ city

Manhattan Beach

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations

Core offering

BodiMetrics develops and sells an FDA-cleared AI-powered wearable device that captures vital health metrics in the palm of the user's hand in 20 seconds, primarily for home-based sleep apnea detection. The device was developed in partnership with EnsoData Inc. and combines wearable hardware with AI-driven sleep analysis to enable accessible, portable sleep apnea testing outside clinical facilities.

Product overview

BodiMetrics offers an FDA-cleared AI-powered wearable device designed for accessible home-based sleep apnea detection. The company has partnered with EnsoData Inc. to deliver this medical-grade wearable solution that enables users to monitor and detect sleep apnea without requiring clinical visits.

Differentiator

Problem solved

Functional benefit

Products and services

• BodiMetrics Sleep Apnea Detection Device

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature1 record

Partnerships

One partnership is on record.

• EnsoData Inc.coreTechnology or Integration · 1 December 2024In December 2024, BodiMetrics LLC partnered with EnsoData Inc. to launch an FDA-cleared AI-powered wearable device for accessible sleep apnea detection. This partnership combines BodiMetrics' wearable device technology with EnsoData's AI-powered sleep analysis capabilities to create a comprehensive home-based sleep apnea testing solution.

Recent moves3 records

Expansion highlights3 records

Direct peers

• EnsoData Inc. EnsoData is BodiMetrics' direct launch partner and is itself an AI-powered sleep scoring platform that analyzes physiological signals to detect and grade sleep apnea. It is the most directly comparable peer because the companies are co-delivering the same FDA-cleared home sleep apnea detection solution.
• Itamar Medical (ZOLL Itamar): Itamar's WatchPAT is an FDA-cleared, portable, at-home sleep apnea testing device targeting the same home-based diagnosis workflow as BodiMetrics. Both are prescribed home sleep testing devices built around simplified at-home patient setup.
• Nox Medical: Nox Medical produces home sleep testing and PSG hardware/software used by clinicians for sleep apnea diagnosis, directly overlapping with BodiMetrics' core home sleep apnea testing use case. Comparable on the diagnosis modality, channel (clinicians/sleep labs), and patient population.
• Compumedics: Compumedics manufactures clinical sleep diagnostics hardware and software (including home sleep testing systems like Somte) used in sleep labs and clinics. Directly comparable as a sleep diagnostics device vendor serving similar HCP customers.

Broad incumbents

• ResMed: ResMed is the largest incumbent in sleep apnea, with PAP therapy devices, masks, and increasingly connected diagnostics and screening (e.g., SleepView-type HST, myAir). It serves the same patient population and clinicians as BodiMetrics but as part of a much broader sleep and respiratory care portfolio.
• Philips Respironics: Philips is a broad incumbent in sleep apnea and respiratory care with Alice NightOne home sleep testing, PAP therapy, and sleep lab systems. Like ResMed, it overlaps with BodiMetrics' home sleep apnea testing use case but operates at vastly larger scale and across a full sleep care portfolio.
• Apple: Apple added FDA-cleared sleep apnea notifications to Apple Watch in 2024 and is the dominant consumer wearable platform for at-scale sleep tracking. It competes for end-user attention and at-home screening demand more than for clinical sleep lab channels, but its reach imposes a competitive ceiling on niche FDA-cleared wearables like BodiMetrics.

Emerging players

• Withings: Withings sells connected health devices (ScanWatch with sleep apnea detection, sleep analyzers) that compete in the consumer-grade at-home sleep monitoring space adjacent to BodiMetrics' wearable. Comparable on home sleep apnea monitoring via wearable, though positioned as a consumer wellness device rather than FDA-cleared diagnostic.
• Oura: Oura's smart ring is a popular consumer wearable with advanced sleep tracking and emerging sleep health features. Comparable as a wearable sleep tech device for health-conscious consumers, though currently not FDA-cleared for sleep apnea diagnosis.
• Whoop: Whoop is a subscription-based health wearable offering continuous sleep, strain, and recovery monitoring, with growing sleep apnea and respiratory insights. Comparable on wearable form factor and consumer-facing health monitoring that overlaps with BodiMetrics' positioning.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/bodimetrics

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bodimetrics